Newsletter - December 8, 2022
Cancer Clinical Trial Data is Rarely Made Public
A survey of publications for cancer clinical research in major journals found that in about 20% of the papers, the authors promised public availability of the data related to their research and only about 1% provided data that met accepted standards for completeness and transparency. Most journals require data...Read More
Independent Panel Recommends Significant Changes to Food Regulation by FDA
An external panel of experts tasked with reviewing FDA’s current practices for regulation of food supply chain recommended a proactive approach to supply chain regulation and restructuring FDA’s organization to create clearer leadership at FDA for food regulation. These organizational changes, if implemented, will streamline...Read More
Cancer Clinical Trial Data is Rarely Made Public
A survey of publications for cancer clinical research in major journals found that in about 20% of the papers, the authors promised public availability of the data related to their research and only about 1% provided data that met accepted standards for completeness and transparency. Most journals require data...Read More
Independent Panel Recommends Significant Changes to Food Regulation by FDA
An external panel of experts tasked with reviewing FDA’s current practices for regulation of food supply chain recommended a proactive approach to supply chain regulation and restructuring FDA’s organization to create clearer leadership at FDA for food regulation. These organizational changes, if implemented, will streamline...Read More
